Fundraising Fox

IconOVir Bio

New York, US · Founded 2018 · Delaware corporation · 8 employees on LinkedIn · 4 known investors

Find your way into IconOVir Bio

Iconovir is a biotechnology company focused on developing cancer treatments, with a stated mission to cure cancer and restore life to patients.

BiotechHealthtech

Founders & leadership

SASean Algeo
Sean AlgeoinVP Finance - Controller & Treasurer
MAMark A. McCamish
Mark A. McCamishinPresident and CEO
DMDavid M. Tanen
David M. TanenNamed on SEC filingAdvisor at Vida Ventures

Board

DCDavid Chang
David ChangBoard directorScientific Advisor at Vida Ventures
HKHelen Kim
Helen KimBoard directorSenior Managing Director at Vida Ventures
JLJakob Loven
Jakob Lovenin𝕏Board Member2021–2024Partner at Nextech Invest
JKJoshua Kazam
Joshua KazamBoard directorCo-Founder and Director at Vida Ventures
ASArie S. Belldegrun
Arie S. Belldegrunin𝕏Board directorFounder and Senior Managing Director at Vida Ventures

Investors · 4

GV (Google Ventures)Mountain View · $250K – $50M
Nextech InvestZurich · $648K – $3.2M
Vida Venturesreported · 2 sourcesLos Angelesvia Arie Belldegrun · board
Wellington ManagementreportedBoston · $5M – $50M

Reported raises · per SEC filings

Form D private placements

$97.2M disclosed across 2 rounds · 2020–2023

▶$20.2MraisedJun 2024 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean AlgeoExecutive Officer, Promoter
  • Nicole van de LeuvExecutive Officer
  • Helen KimDirector
  • Heba NowyhedExecutive Officer
  • David ChangDirector, Promoter
  • William KaelinDirector
  • Jakob LovenDirector
  • Joshua KazamDirector, Promoter
  • Julie MaltzmanExecutive Officer
  • Mark A. McCamishExecutive Officer, Director
  • John HuynhExecutive Officer
  • David M. TanenExecutive Officer, Promoter
Offering amount
$20.2M
Amount sold
$20.2M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$77MraisedDec 2020 · 47 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David ChangDirector, Promoter
  • Helen KimDirector
  • Sean AlgeoExecutive Officer, Promoter
  • Jakob LovenDirector
  • Mark A. McCamishExecutive Officer, Director
  • Joshua A. KazamDirector
  • David M. TanenExecutive Officer, Promoter
  • Arie S. BelldegrunDirector, Promoter
Offering amount
$77M
Amount sold
$77M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through IconOVir Bio went on to found or lead other companies.

Arie BelldegrunDirector, PromoterFounded Kite PharmaJakob LovenDirectorFounded Relay

Competitors · 1

by search overlap
Vir5 shared keywordsVir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities. The company targets patients with unmet medical needs across these therapeutic areas.

Companies competing with IconOVir Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

7 oncolytic virus companies revolutionizing cancer treatmentlabiotech.eu · Mar 2024IconOVir raises $77M to Fight Cancer with Viruses - Xtalksxtalks.com · Jan 2021IconOVir uncloaks with $77M, ex-Forty Seven CEO and cancer-killing viruses out of Salk Institute | Fierce Biotechfiercebiotech.com · Jan 2021Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases - BioSpacebiospace.com · Jan 2021IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumorsbusinesswire.com · Jan 2021IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumors - IconOViriconovir.com · Jan 2021

Frequently asked questions

What does IconOVir Bio do?
Iconovir is a biotechnology company focused on developing cancer treatments, with a stated mission to cure cancer and restore life to patients.
Who are IconOVir Bio's investors?
IconOVir Bio's investors include GV (Google Ventures), Nextech Invest, Vida Ventures, Wellington Management.
How much funding has IconOVir Bio raised?
IconOVir Bio has disclosed $97.2M raised across 2 rounds.
Where is IconOVir Bio headquartered?
IconOVir Bio is headquartered in New York, US.